- Home
- ADTX vs INM Comparison
ADTX vs INM Comparison
Compare ADTX & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- INM
- Stock Information
- Founded
- ADTX 2017
- INM 1981
- Country
- ADTX United States
- INM Canada
- Employees
- ADTX N/A
- INM N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ADTX Health Care
- INM Health Care
- Exchange
- ADTX Nasdaq
- INM Nasdaq
- Market Cap
- ADTX 3.1M
- INM 3.2M
- IPO Year
- ADTX 2020
- INM N/A
- Fundamental
- Price
- ADTX $1.20
- INM $2.66
- Analyst Decision
- ADTX
- INM
- Analyst Count
- ADTX 0
- INM 0
- Target Price
- ADTX N/A
- INM N/A
- AVG Volume (30 Days)
- ADTX 2.0M
- INM 5.8M
- Earning Date
- ADTX 08-18-2025
- INM 05-12-2025
- Dividend Yield
- ADTX N/A
- INM N/A
- EPS Growth
- ADTX N/A
- INM N/A
- EPS
- ADTX N/A
- INM N/A
- Revenue
- ADTX $55,323.00
- INM $4,920,990.00
- Revenue This Year
- ADTX $15,768.94
- INM N/A
- Revenue Next Year
- ADTX N/A
- INM N/A
- P/E Ratio
- ADTX N/A
- INM N/A
- Revenue Growth
- ADTX N/A
- INM N/A
- 52 Week Low
- ADTX $1.05
- INM $1.72
- 52 Week High
- ADTX $21,400.00
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ADTX 39.51
- INM 45.77
- Support Level
- ADTX $1.13
- INM $2.69
- Resistance Level
- ADTX $1.30
- INM $3.28
- Average True Range (ATR)
- ADTX 0.11
- INM 0.20
- MACD
- ADTX 0.03
- INM -0.05
- Stochastic Oscillator
- ADTX 46.81
- INM 9.81
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics, the way bodies naturally induce tolerance to tissues.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.